MiMedx Lands a Date With the FDA
MiMedx to meet with FDA on October 28t
MARIETTA, Ga., Oct. 17, 2013 /PRNewswire/ – MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human…
View Post








